PrevenTRON Trial Tests Blood Biomarkers to Delay Alzheimer’s Symptom Onset
Medical research is shifting toward a preemptive model for Alzheimer’s disease, utilizing blood-based biomarkers to identify high-risk individuals years before clinical symptoms manifest. A centerpiece of this effort is the PrevenTRON trial, which was presented at the Alzheimer’s Association International Conference (AAIC) held in London from July 12 to 15, 2026. The PrevenTRON Trial: Targeting … Read more